Clearside Biomedical, Inc.

Clearside Biomedical, based in Raleigh, NC, is a pioneering biopharmaceutical company focused on revolutionizing the treatment of retinal diseases. Their innovative technology allows for precise drug delivery to the back of the eye, targeting irreversible ocular conditions with unprecedented access.

With the first FDA-approved product for suprachoroidal administration, XIPERE, Clearside Biomedical is dedicated to developing therapies that preserve and enhance vision for individuals suffering from serious back-of-the-eye diseases. Their commitment to clinical excellence and cutting-edge research sets them apart in the field of ophthalmology.

Generated from the website